Table 2 Commonly used intravitreal antibacterial drugs used for pharmacotherapy of bacterial endogenous endophthalmitis
From: Endogenous endophthalmitis: diagnosis, management, and prognosis
| Drug | Intravitreal dose | Reference |
|---|---|---|
| A. Gram-positive bacteria (including VSSA) | ||
| Vancomycin | 1 mg/0.1 ml | [12, 26, 44] |
| Cefazolin | 2.25 mg/0.1 ml | |
| B. Gram-positive bacteria—VRSA | ||
| Daptomycin | 200 μg/0.1 ml | [27] |
| Quinupristin/dalfopristin | 0.4 mg/0.1 ml | [62] |
| C. Gram-negative bacteria | ||
| Ceftazidime | 2.25 mg/0.1 ml | [12, 26] |
| Amikacin | 0.4 mg/0.1 ml | [89] |
